Search Filters

  • Media Source
  • Presentation Format
  • Media Type
  • Media Year
  • Language
  • Diagnosis / Condition
  • Diagnosis Method
  • Patient Populations
  • Treatment / Technique

The Statistical Fragility of Tourniquet Use In Total Knee Arthroplasty: A Systematic Review

The Statistical Fragility of Tourniquet Use In Total Knee Arthroplasty: A Systematic Review

Kyle William Lawrence, BS, UNITED STATES John K Cordero, MD, UNITED STATES Ashley Brown, BS, UNITED STATES Xinning Li, MD, UNITED STATES Brett Hayden, MD, UNITED STATES Robert L Parisien, MD, UNITED STATES

Icahn School of Medicine at Mount Sinai, New York, New York, UNITED STATES


2023 Congress   ePoster Presentation   2023 Congress   Not yet rated

 

Anatomic Location

Anatomic Structure

Diagnosis / Condition

Treatment / Technique


Summary: Statistical fragility exists in RCTs on tourniquet use in TKA, especially for statistically significant results. Altering a small number of outcomes is sufficient to reverse study findings. Reporting FI and FQ values may provide a more reliable representation of study conclusions in RCTs in TKA.


Background

Fragility index (FI) and reverse fragility index (reverse FI) are informative metrics for evaluating the robustness of clinical trial data, representing the number of outcome event reversals necessary to change the significance of a study.

Methods

We queried PubMed/EMBASE/MEDLINE for randomized controlled trials (RCTs) comparing outcomes in total knee arthroplasty (TKA) where study groups were stratified by tourniquet-use strategy. FI and reverse FI were determined – for significant and non-significant outcomes, respectively – by determining the number of outcome reversals required to change statistical significance. The fragility quotient (FQ) was calculated by dividing the FI or reverse FI by the sample size. Subgroup analysis was performed by outcome type.

Results

Literature search yielded 23 studies from 18 orthopaedic journals reporting a total of 91 dichotomous outcomes. The median FI of the 91 outcome events was 4 (IQR 3-6) with an FQ of 0.0476 (IQR 0.0291-0.0867). 11 outcomes were reported as statistically significant with a median FI of 2 (IQR 1.5-5) and a median FQ of 0.0200 (IQR 0.0148-0.0484). 80 outcomes were reported as non-significant with a median reverse FI of 4 (IQR 3-6) and a median FQ of 0.0495 (IQR 0.0310-0.0887). Outcomes were categorized into skin/wound complications, transfusion requirement, deep vein thrombosis, postoperative pain, and re-intervention, with FIs of 4 (IQR 3-6), 3 (IQR 2-5), 4 (IQR 4-6), 5.5 (IQR 5-7.5), and 3 (IQR 3-4.5), respectively. Total patients lost to follow-up was greater than the median FI in 17.6% of outcomes.

Conclusions

Statistical fragility exists in RCTs on tourniquet use in TKA, especially for statistically significant results. Altering a small number of outcomes is sufficient to reverse study findings. Reporting FI and FQ values may provide a more reliable representation of study conclusions in RCTs on tourniquet use in TKA.


More 2023 ISAKOS Congress Content